CSBR - チャンピオンズ・オンコロジ― （Champions Oncology Inc.）CSBRのニュース
Champions Oncology Trades At A Sufficient Discount To R&D Capacity (NASDAQ:CSBR) 2023/01/29 05:37:56 Seeking Alpha
CSBR runs a PDX bank. PDXs are mice models of human derived tumors.
CALA , NUWE and CORZ among mid-day movers 2022/12/15 17:42:38 Seeking Alpha
Gainers: Icosavax (ICVX) +62%.Core Scientific (CORZ) +36%.Kintara KTRA +27%.Mullen Automotive MULN +26%.Clearmind Medicine CMND +26%.Champions Oncology (CSBR) +24%.Neonode…
Champions Oncology, Inc. (CSBR) Q2 2023 Earnings Call Transcript 2022/12/14 01:54:06 Seeking Alpha
Champions Oncology, Inc. (NASDAQ:NASDAQ:CSBR) Q2 2023 Results Conference Call December 13, 2022 04:30 PM ET Company Participants Ronnie Morris - CEO David Miller - CFO Conference Call…
Champions Oncology Non-GAAP EPS of $0.01 misses by $0.01, revenue of $14.28M beats by $0.34M (NASDAQ:CSBR) 2022/12/13 21:43:14 Seeking Alpha
Champions Oncology press release (CSBR): Q2 Non-GAAP EPS of $0.01 misses by $0.01.Revenue of $14.28M (+21.1% Y/Y) beats by $0.34M.Adjusted EBITDA of $686,000Discovery…
Champions Oncology, Inc.: Champions Oncology Reports Record Quarterly Revenue of $14.3 Million 2022/12/13 21:02:00 Finanz Nachrichten
HACKENSACK, NJ / ACCESSWIRE / December 13, 2022 / Champions Oncology, Inc. (Nasdaq:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-drive…
Why ZW Data Action Technologies Jumped 37%; Here Are 71 Biggest Movers From Yesterday 2022/09/16 08:38:59 Benzinga
Gainers HeartBeam, Inc. (NASDAQ: BEAT ) shares jumped 85.6% to close at $2.32 on Thursday after the company announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome and cardiac arrhythmia was issued by the USPTO. NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO ) rose 47.2% to close at $24.82 after the company announced Dong-A has licensed its global exclusive development rights of DA-1241 for type 2 diabetes and non-alcoholic fatty hepatitis and DA-1726 for obesity and non-alcoholic fatty hepatitis to NeuroBo. Nabriva Therapeutics plc (NASDAQ: NBRV ) climbed 39.4% to close at $0.2671 after the company announced it will effect a 1-for-25 reverse stock split of its outstanding ordinary shares, which will be effective on September 16, 2022. ZW Data Action Technologies Inc. (NASDAQ: CNET ) gained 37.4% to close at $0.91. ZW Data Action Technologies reported planned acquisition of Henan Baodun. ZeroFox Holdings, Inc. (NASDAQ: ZFOX ) gained 32.7% to close at $7.76.
Champions Oncology, Inc. (CSBR) Q1 2023 Earnings Call Transcript 2022/09/09 20:41:05 Seeking Alpha
Champions Oncology, Inc. (NASDAQ:NASDAQ:CSBR) Q1 2023 Earnings Conference Call September 8, 2022, 04:30 PM ET Company Participants Ronnie Morris - CEO David Miller - CFO Conference Call…
Champions Oncology GAAP EPS of -$0.02 misses by $0.03, revenue of $13.7M beats by $0.51M 2022/09/08 20:18:16 Seeking Alpha
Champions Oncology press release (CSBR): Q1 GAAP EPS of -$0.02 misses by $0.03.Revenue of $13.7M (+21.2% Y/Y) beats by $0.51M.Adjusted EBITDA of $450,000.The Company ended the…
Champions Oncology Reports Record Quarterly Revenue of $13.7 Million 2022/09/08 20:00:00 Wallstreet:Online
HACKENSACK, NJ / ACCESSWIRE / September 8, 2022 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic integration, today …
Earnings Preview For Champions Oncology 2022/09/07 14:10:34 Benzinga
Champions Oncology (NASDAQ: CSBR ) is set to give its latest quarterly earnings report on Thursday, 2022-09-08. Here''s what investors need to know before the announcement. Analysts estimate that Champions Oncology will report an earnings per share (EPS) of $0.01. Champions Oncology bulls will hope to hear the company to announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for … Full story available on Benzinga.com
Champions Oncology Inc (NASDAQ:CSBR) is debt free 2021/12/14 16:29:47 FXDailyReport
Champions Oncology Inc (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative pharmacology, biomarker, and data platforms, stock rose 3.23% (As The post Champions Oncology Inc (NASDAQ:CSBR) is debt free appeared first on FXDailyReport.Com .
Champions Oncology, Inc. (CSBR) Q2 2022 Earnings Call Transcript 2021/12/14 00:44:32 AlphaStreet
Champions Oncology, Inc. (NASDAQ: CSBR) Q2 2022 earnings call dated Dec. 13, 2021. Corporate Participants: Ronnie Morris — President & Chief Executive Officer David Miller — Chief Financial Officer Analysts: Matt Hewitt — Craig-Hallum — Analyst […] The post Champions Oncology, Inc. (CSBR) Q2 2022 Earnings Call Transcript first appeared on AlphaStreet .
Champions Oncology Inc.''s (CSBR) CEO Ronnie Morris on Q2 2022 Results - Earnings Call Transcript 2021/12/14 00:33:02 Seeking Alpha
Champions Oncology, Inc.: Champions Oncology Reports Record Quarterly Revenue of $11.8 Million 2021/12/13 21:32:00 FinanzNachrichten
Reported income from operations of $263,000HACKENSACK, NJ / ACCESSWIRE / December 13, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming…